Turning One-Time Patients Into Repeat Peptide Buyers

the hardest number to move in a med spa peptide program is not cost per acquisition. it is month three. patients enroll enthusiastically, take the product, and then quietly disappear somewhere between week five and week nine — usually not because it did not work, but because nobody was in contact with them at the moment they wavered. retention is a system, and most clinics have not built one.

the math that should reframe your priorities

take a program at $299/month with roughly $140 gross margin and a $120 acquisition cost.

• —2-month average life: $280 gross margin, $160 net after acquisition. barely a business.
• —4 months: $560 gross, $440 net. workable.
• —6 months: $840 gross, $720 net. now you can spend aggressively on ads.
• —9 months: $1,260 gross, $1,140 net. now you can outbid everyone in your market.

going from 4 months to 6 adds $280 per patient. cutting your CPA by 20% adds $24. clinics spend most of their energy on the $24. the retention work is roughly ten times more valuable and it is entirely within your control — no auction, no algorithm.

why patients actually quit

the reasons are consistent and mostly addressable, and almost none of them are price.

1. 1.no early win. they did not feel anything by week three and concluded it was not working. this is an expectations problem you create at onboarding.
2. 2.a side effect nobody prepared them for. they got nauseous or fatigued, no one had warned them, and quitting felt like the safe response.
3. 3.confusion about how to use it. reconstitution, dosing, storage, timing. an uncertain patient stops.
4. 4.they ran out and the refill did not arrive. once the chain breaks, restarting requires activation energy most people do not spend.
5. 5.silence. nobody checked in, so the program felt transactional and the charge started feeling like a subscription they forgot to cancel.
6. 6.price, occasionally — but far less often than clinics assume.

notice that five of the six are communication failures. that is good news, because communication is cheap.

system 1: onboarding that gets them to a first win

the first 14 days determine most of your retention curve. the goal is not education for its own sake — it is to make the patient feel competent, prepared, and in contact with a human.

1. 1.day 0, immediately after purchase: what happens next and exactly when. remove all ambiguity about the provider review and shipping timeline.
2. 2.day of delivery: how to store it, how to use it, a short video from your actual provider. video dramatically outperforms text here.
3. 3.day 2: what to expect in weeks one through four, including honest side effects and what is normal. patients who are warned do not panic.
4. 4.day 5: a real human check-in that invites a reply. an actual question, not a newsletter.
5. 5.day 10: one non-product habit that improves their outcome — protein, sleep, walking. this makes you a partner rather than a vendor.
6. 6.day 14: first milestone check-in and the first testimonial ask, phrased as a question about their experience.

the day 2 side-effect email is the highest-ROI message in the entire sequence. patients who experience an unexpected symptom with no warning quit. patients who were told to expect it and told what to do call it normal.

system 2: a check-in cadence that catches the wobble

cancellations are almost always preceded by a quiet period. the fix is to make sure there is no quiet period in the first 90 days.

• —week 2 and week 4: structured check-ins that ask specific questions rather than 'how is it going'
• —week 6-8: the danger zone. this is where the initial novelty is gone and results may be plateauing. a provider touchpoint here is worth more than three marketing emails.
• —month 3: a progress review that reframes expectations for the next phase
• —flag non-responders. a patient who has not replied to two consecutive check-ins is a patient about to cancel — that list should go to a human, not an automation.
• —flag anyone whose card failed or who opened the cancel page. that is a real-time signal.

system 3: reorder before they run out

the mechanical retention killer is a gap in supply. once a patient has been without product for a week, they have effectively quit, whether or not they have cancelled.

1. 1.know the actual consumption timeline per program and trigger the refill process 7-10 days before depletion
2. 2.auto-refill by default with an easy skip or pause. defaults matter enormously.
3. 3.run dunning properly on failed cards — a substantial share of churn is involuntary and recoverable with three retries and a clear email
4. 4.send tracking proactively. a patient who does not know where their shipment is opens a support ticket, and an unanswered ticket becomes a chargeback.
5. 5.for programs requiring periodic provider re-evaluation, schedule that ahead of the refill so clinical review never becomes the supply gap

involuntary churn is the easiest revenue in the business to recover. many clinics lose 5-10% of their active base monthly to expired cards alone and never notice, because it does not look like cancellation in any report they read.

the med spa advantage: you have a building

an online-only peptide brand can only email a wavering patient. you can invite them in. that is a retention tool nobody else in the category has.

• —offer a complimentary in-clinic progress check at month 3 — it saves cancellations and it fills the schedule
• —bundle a small in-clinic service into longer program commitments
• —cross-sell in both directions: program patients into injectables and skin services, aesthetic patients into programs
• —run patient events. a clinic with a community has a retention rate an e-commerce brand cannot approach.
• —have the front desk greet program patients by name when they come in. it sounds trivial and it is not.

the peptide business is won at month three, not at the click. every dollar spent on acquisition is leveraged by whatever your retention curve happens to be.

what to measure

1. 1.month-2, month-3 and month-6 retention rates as separate numbers — one blended churn figure hides where the leak is
2. 2.involuntary churn separated from voluntary churn
3. 3.average patient life in months, tracked by cohort
4. 4.reorder flow performance and dunning recovery rate
5. 5.cancellation reasons, collected in a one-question exit survey
6. 6.check-in reply rate as a leading indicator — it falls before revenue does

one boundary worth naming: retention tactics must never conflict with clinical judgment. if a patient should not continue, they should not continue, and no flow should make cancelling difficult. beyond being the right thing, retention-by-friction generates chargebacks and regulatory complaints. this is operational guidance, not medical or legal advice — clinical decisions belong to your provider and your protocols.